Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria

QR Code

Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria

© 2016.There are limited data on gametocytaemia risk factors before/after treatment with artemisinin combination therapy in children from areas with transmission of multiple Plasmodium species. We utilised data from a randomised trial comparing artemether-lumefantrine (AL) and artemisinin-naphthoqui...

Full description

Bibliographic Details
Main Authors:	Karl, S., Laman, M., Moore, Brioni, Benjamin, J., Salib, M., Lorry, L., Maripal, S., Siba, P., Robinson, L., Mueller, I., Davis, T.
Format:	Journal Article
Published:	Elsevier 2016
Online Access:	http://hdl.handle.net/20.500.11937/7314

Similar Items

Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission
by: Arnott, A., et al.
Published: (2014)

Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: A six months post-treatment follow-up study
by: Laman, M., et al.
Published: (2015)

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
by: Laman, M., et al.
Published: (2014)

Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria
by: Laman, M., et al.
Published: (2014)

Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria
by: Karl, S., et al.
Published: (2014)

Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
by: Moore, Brioni, et al.
Published: (2017)

Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea
by: Koleala, T., et al.
Published: (2015)

Population Pharmacokinetics of Artemether, Lumefantrine, and Their Respective Metabolites in Papua New Guinean Children with Uncomplicated Malaria
by: Salman, S., et al.
Published: (2011)

Effect of coadministered fat on the tolerability, safety and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria
by: Moore, Brioni, et al.
Published: (2014)

Gametocyte clearance kinetics determined by quantitative magnetic fractionation in Melanesian children with uncomplicated malaria treated with artemisinin combination therapy
by: Karl, S., et al.
Published: (2015)

Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: Feasibility of abbreviated high-dose regimens for radical cure of vivax malaria
by: Moore, Brioni, et al.
Published: (2014)

Absence of Plasmodium inui and Plasmodium cynomolgi, but detection of Plasmodium knowlesi and Plasmodium vivax infections in asymptomatic humans in the Betong division of Sarawak, Malaysian Borneo
by: Siner, Angela, et al.
Published: (2017)

Orangutans not Infected with Plasmodium vivax or P. cynomolgi, Indonesia
by: Balbir, Singh, et al.
Published: (2009)

Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria
by: Salman, S., et al.
Published: (2012)

Plasmodium Vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New Guinea
by: Genton, B., et al.
Published: (2008)

Mitochondrial DNA from the eradicated European Plasmodium vivax and P. falciparum from 70-year-old slides from the Ebro Delta in Spain
by: Gelabert, P., et al.
Published: (2016)

Identification of unique molecular markers of Plasmodium vivax from Malaysian Borneo
by: Lau, Tiek Ying
Published: (2006)

Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1)
by: Arnott, A., et al.
Published: (2013)

A study of the PfNT3 in Plasmodium falciparum
by: Sahu Pratima Kumari,, et al.
Published: (2015)

Origin of Plasmodium falciparum malaria is traced by mitochondrial DNA
by: Conway, D.J
Published: (2000)

The timing of action of artemisinin on the malaria parasite, plasmodium falciparum
by: Desa, Nurul Wahida Md
Published: (2016)

The prosegment catalyzes native folding of Plasmodium falciparum plasmepsin II
by: Jaafar, Ahmad Haniff, et al.
Published: (2016)

The effect of artemisinin on the pH of plasmodium falciparum digestive vacuole
by: Ibrahim, Nadiah
Published: (2020)

Assessment of phagocytosis and cytokine secretions by monocytes in the presence of plasmodium falciparum
by: Xuan, Keh Min
Published: (2021)

Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children
by: Irani, V., et al.
Published: (2015)

Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women
by: Benjamin, J., et al.
Published: (2015)

Meningeal inflammation increases cerebrospinal fluid artemether concentrations in Papua New Guinean children treated with intramuscular artemether
by: Manning, L., et al.
Published: (2011)

PHARMACOKINETICS OF TRANSFER OF PIPERAQUINE INTO THE BREAST MILK OF PAPUA NEW GUINEAN MOTHERS
by: Moore, B., et al.
Published: (2015)

Fragmented Population Structure of Plasmodium falciparum in a Region of Declining Endemicity
by: Anthony, Thomas G., et al.
Published: (2005)

Molecular characterisation of the plasmodium falciparum pfcrt gene involved in chloroquine resistance
by: Lau, Hui Chong
Published: (2008)

Construction of dna vaccine expressing msp-1c of plasmodium falciparum
by: Noraini, Mat Yunus
Published: (2008)

The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
by: Thuduhena, Thuduhenage Dona Anjana Chamilka
Published: (2024)

Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections
by: Daneshvar, C., et al.
Published: (2010)

Maternal Antibodies to Pneumolysin but Not to Pneumococcal Surface Protein A Delay Early Pneumococcal Carriage in High-Risk Papua New Guinean Infants
by: Francis, Jacinta, et al.
Published: (2009)

Andrographolide effect on both Plasmodium falciparum infected and non infected RBCs membranes
by: Ibraheem, Zaid Osamah, et al.
Published: (2015)

Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
by: Mukap, M., et al.
Published: (2018)

Lansium Domesticum: In Vitro Antimalarial Bioactivity And Its Effect On Plasmodium Falciparum Gene Expression
by: Angela, Siner
Published: (2013)

Antiplasmodium and chloroquine resistance reversing effects of embelin against Plasmodium falciparum K1
by: Ibraheem, Zaid Osama, et al.
Published: (2015)

The effect 0f pyrogallol 0n the ph of plasmodium falciparum digestive vacuole
by: Omar, Alfaqih Hussain
Published: (2020)

Synergistic effects of GSK3 and p38 MAPK inhibitors on growth of Plasmodium falciparum ex vivo
by: Marhalim, L., et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bf1a96qg5gcdofh1pnf0v212qd